Home > Financial Ratios > INDEGENE
AD     Remove this Ad

INDEGENE Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.370.360.250.140.21

What is the latest Fixed Capital/Sales ratio of INDEGENE ?

The latest Fixed Capital/Sales ratio of INDEGENE is 0.37 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.37
Mar20240.36
Mar20230.25
Mar20220.14
Mar20210.21

How is Fixed Capital/Sales of INDEGENE Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.37
2.78
Mar2024 0.36
44.00
Mar2023 0.25
78.57
Mar2022 0.14
-33.33
Mar2021 0.21 -

Other Financial Ratios of INDEGENE


Compare Fixed Capital/Sales ratio of peers of INDEGENE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDEGENE ₹11,778.8 Cr -0.3% 10.3% -9.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


INDEGENE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDEGENE

-0.3%

10.3%

-9.9%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses